Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 65 for “"DMPK"”.
-
DMPK isoforms in muscle and brain cells. Localization and function.
Contains fulltext : 85871.pdf (Publisher’s version ) (Open Access)
-
DMPK E and Lats2 in the cell division cycle. Study of two AGC kinases
Radboud Universiteit Nijmegen, 05 april 2012
-
Molecular aspects of myotonic dystrophy type 1, expression and silencing of DMPK gene products.
Contains fulltext : 91254.pdf (Publisher’s version ) (Open Access)
-
Characterisation of phenol hydroxylase and its auxiliary proteins, DmpM and DmpK, from pseudomonas spl Strain CF600
… The oxygenase requires an accessory protein, DmpK, for diiron cluster assembly. This thesis describes the characterisation of DmpM, DmpK, and DmpLNO. DmpM was found to exist in two forms. DmpM purified from the native strain was active in stimulating phenol hydroxylase activity, whereas an …
-
A role for RNA localization in the human neuromuscular disease myotonic dystrophy
… by a (CTG)n expansion in the DM kinase (DMPK) gene 3' untranslated region while DM2 has a mutation in a small presumptive RNA binding protein. These analyses were guided by disease characteristics and have provided insights to DM's cytopathology, cell biology and molecular genetics. …
-
Identificação e avaliação da distribuição alélica de repetições do trinucleotídeo CTG no gene DMPK em indivíduos saudáveis e em pacientes com distrofia miotônica tipo 1
O gene DMPK (Dystrophia Myotonica-Protein Kinase) humano está localizado no locus 19q13.3, sendo dividido em 15 éxons, com uma região polimórfica de repetições CTG em sua região 3’ não traduzida. Indivíduos normais apresentam de 5 a 34 repetições CTG. Indivíduos com alelos com mais de 50 repetições …
-
Effects of the myotonic dystrophy mutation in muscle differentiation and apoptosis.
… threonine p&barbelow;rotein k&barbelow;inase, DMPK. Normal individuals possess 5--35 CTG repeats, typical adult DM patients have repeat sizes ranging from 80 to 1000 while cDM patients have from 1000 to several thousand CTG repeats. This discovery provided a molecular basis to account for large …
-
In Silico Mining of a System Wide Transcriptional Profiling Database for Clinically Relevant Gene Modulation by FDA Approved or FDA Ready Agents; Validation of a Novel Translational Approach
… stems from an expanded CTG repeat found in the DMPK gene. The down regulation of DMPK mRNA represents a valid therapeutic avenue. DMD is characterized by degeneration of muscle, caused by mutations in the dystrophin gene. One therapeutic strategy for DMD is to increase the dystrophin homologue …
-
Binding of MBNL1 to CUG repeats slows 5'-to-3' RNA decay by XRN2 in a cell culture model of type I myotonic dystrophy
… UTR of the dystrophia myotonica protein kinase (DMPK) gene. The encoded CUG repeat-containing mRNAs are toxic to the cell and accumulate in nuclear foci, where they sequester cellular RNA-binding proteins such as the splicing factor Muscleblind-1 (MBNL1). This leads to widespread changes in gene …
-
RNAi Screening of the Kinome Identifies PACT as a Novel Genetic Modifier of Foci Integrity in Myotonic Dystrophy type 1
… of a tri-nucleotide repeat in the 3' UTR of the DMPK gene results in DMPK mRNA hairpin structures, aggregating as insoluble ribonuclear foci. The resulting mis-regulation of important splicing factors, causes the inclusion of fetal exons in dozens of transcripts that contribute to the disease …
-
Molecular and preclinical aspects of antisense oligonucleotide treatment for myotonic dystrophy type 1
… caused by an expansion of a (CTG)n repeat in the DMPK gene, which is carried by all individuals, but normally contains less than 37 triplets. Only when this threshold is exceeded the person carrying it will develop DM1, with an age of onset and severity that loosely correlates with (CTG)n length: …
-
High-Throughput Screening of Kinase siRNAs and Small Molecule Compounds Identify Novel Candidates for the Development of Myotonic Dystrophy Type 1 Therapies: A Step Towards Therapeutic Advancements in DM1
… of the dystrophia myotonica protein kinase (DMPK) gene. The expanded repeats of the DMPK mRNA forms hairpin structures which sequester RNA-binding proteins (RBP) in intranuclear foci, such as the splicing regulator muscleblind-like 1 (MBNL1), which results in aberrant splicing of several …
-
Analysis and Modulation of PACT, DICER and MBNL1 in the Context of Myotonic Dystrophy Type I
… the nuclear retention of pathogenically expanded DMPK mRNA. A previous DM1 RNAi-kinome screen in our lab has identified kinases that reduced both count and area of DMPK mRNA foci in vitro. One such discovered kinase is PACT, which has showed to decrease foci count and area in DM1 fibroblasts by …
-
Evaluation of the Allometric Exponents in Prediction of Human Drug Clearance
… and drug metabolism and pharmacokinetics (DMPK) properties of the compounds. 2- Single-species AS was performed to estimate the single-species AS exponent distributions and their corresponding central tendencies. The correlation between the estimated single-species AS exponents and the …
-
Expression and Functional Analysis of the Transcription Factor DMAHP
… kinase gene myotonic dystrophy protein kinase (DMPK) and the promoter region of a homeobox gene myotonic dystrophy associated homeodomain protein (DMAHP). These genes are both expressed in a wide range of tissues and their levels of expression have been shown to be altered in DM patients. DMAHP …
-
Investigating and exploiting best practices in hit identification and hit to lead chemistry
… activity in a cellular assay and excellent DMPK profiles, making them high quality tools for target validation experiments. A comparative data analysis was carried out to compare the physicochemical properties of molecules discovered by FBDD, high throughput screening (HTS) and encoded …
-
Investigating the Therapeutic Potential of AMP-Activated Protein Kinase in Myotonic Dystrophy Type 1
… in the dystrophia myotonica protein kinase (DMPK) gene. Mutant DMPK mRNAs accumulate as nuclear foci and cause disruptions in pre-mRNA processing via a toxic gain-of-function mechanism that involves the misregulation of key RNA-binding proteins, such as muscleblind-like splicing regulator 1 …
-
Skeletal muscle adaptations to chronic exercise in a pre-clinical model of myotonic dystrophy type 1
… in the dystrophia myotonica protein kinase (DMPK) gene, DM1 is characterized by muscle weakness, wasting, and myotonia. The expanded nucleotide sequence of the DMPK mRNA results in the misregulation of important RNA-binding proteins (RNABPs), Muscleblind-like 1 (MBNL1) in particular. MBNL1 …
-
Identification and investigation of RNA-binding ligands
… CUG RNA repeat expansion in the 3’-UTR of the DMPK gene that sequesters a key splicing regulator, MBNL1, preventing normal modulation of alternative splicing of a variety of genes. Targeting these repeats with small molecules could block the sequestration of MBNL1 and restore normal splicing …
-
Development of therapeutic agents for myotonic dystrophy type 1
… of the Dystrophia Myotonica Protein Kinase (DMPK) gene on chromosome 19. The genetic basis of DM1 is that DMPK is transcribed into an mRNA transcript with an expanded CUG repeat, r(CUG)exp, which can form hairpin secondary structures. These hairpin structures sequester the muscleblind-like …
Page 1 of 4